Knechtle, Stuart J <br/><br/>
How does alemtuzumab affect long-term graft and patient outcomes after deceased-donor kidney transplantation?  [electronic resource] 

 -  Nature clinical practice. Nephrology  Dec 2005 
 - 74-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1745-8323 
<br/><br/><label>Standard No.: </label>10.1038/ncpneph0052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alemtuzumab<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm--therapeutic use<br/>Cadaver<br/>Graft Survival<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation<br/>Time Factors